MY157955A - Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody - Google Patents

Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody

Info

Publication number
MY157955A
MY157955A MYPI20063118A MYPI20063118A MY157955A MY 157955 A MY157955 A MY 157955A MY PI20063118 A MYPI20063118 A MY PI20063118A MY PI20063118 A MYPI20063118 A MY PI20063118A MY 157955 A MY157955 A MY 157955A
Authority
MY
Malaysia
Prior art keywords
therapeutic antibody
target antigen
detection
absence
sample
Prior art date
Application number
MYPI20063118A
Other languages
English (en)
Inventor
Helmut Lenz
Werner Scheuer
Martina Thier
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MY157955A publication Critical patent/MY157955A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MYPI20063118A 2005-07-06 2006-06-29 Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody MY157955A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05014618 2005-07-06
EP06004447 2006-03-06

Publications (1)

Publication Number Publication Date
MY157955A true MY157955A (en) 2016-08-30

Family

ID=36922121

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20063118A MY157955A (en) 2005-07-06 2006-06-29 Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody

Country Status (19)

Country Link
US (1) US20070009976A1 (https=)
EP (2) EP1902315A1 (https=)
JP (1) JP2008545145A (https=)
KR (1) KR20080016939A (https=)
AR (1) AR053948A1 (https=)
AU (1) AU2006265275A1 (https=)
BR (1) BRPI0612591A2 (https=)
CA (1) CA2613187A1 (https=)
CR (1) CR9635A (https=)
EC (1) ECSP088081A (https=)
IL (1) IL188317A0 (https=)
MA (1) MA29730B1 (https=)
MX (1) MX2008000277A (https=)
MY (1) MY157955A (https=)
NO (1) NO20076662L (https=)
NZ (1) NZ564471A (https=)
RU (1) RU2008103608A (https=)
TW (1) TWI312864B (https=)
WO (1) WO2007003420A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130056201A (ko) * 2000-05-19 2013-05-29 제넨테크, 인크. ErbB 길항제에 의한 암 치료요법에 대한 효과적인 반응의 가능성을 개선시키기 위한 유전자 검출 분석
KR20140032004A (ko) 2004-07-22 2014-03-13 제넨테크, 인크. Her2 항체 조성물
KR101134208B1 (ko) 2004-10-01 2012-04-09 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 촬상 장치 및 그 방법
JO3000B1 (ar) 2004-10-20 2016-09-05 Genentech Inc مركبات أجسام مضادة .
EP1850874B1 (en) 2005-02-23 2013-10-16 Genentech, Inc. Extending time to disease progression or survival in ovarian cancer patients using pertuzumab
PE20070207A1 (es) * 2005-07-22 2007-03-09 Genentech Inc Tratamiento combinado de los tumores que expresan el her
US8358354B2 (en) 2009-01-26 2013-01-22 The Board Of Trustees Of The Leland Stanford Junior University Correction of optical abberations
US8243157B2 (en) 2006-02-07 2012-08-14 The Board Of Trustees Of The Leland Stanford Junior University Correction of optical aberrations
MX2009008981A (es) 2007-03-02 2009-09-02 Genentech Inc Prediccion de respuesta a un inhibidor her.
TWI472339B (zh) 2008-01-30 2015-02-11 Genentech Inc 包含結合至her2結構域ii之抗體及其酸性變異體的組合物
BRPI0812682A2 (pt) 2008-06-16 2010-06-22 Genentech Inc tratamento de cáncer de mama metastático
WO2013055874A2 (en) 2011-10-14 2013-04-18 Genentech, Inc. Uses for and article of manufacture including her2 dimerization inhibitor pertuzumab
KR101327542B1 (ko) * 2012-03-15 2013-11-08 광주과학기술원 양자점 기반의 경쟁 면역분석법 및 다중 유세포 분석법을 이용한 시료 중 오염물질의 검출 방법
AU2012232949B2 (en) * 2012-09-28 2014-07-03 Willowtree Holdings Pty Ltd Temporary bulkhead
RU2019115089A (ru) 2013-04-16 2019-06-11 Дженентек, Инк. Варианты пертузумаба и их аналитическая характеристика
JP2017513901A (ja) 2014-04-25 2017-06-01 ジェネンテック, インコーポレイテッド トラスツズマブ−mcc−dm1及びペルツズマブにより早期の乳癌を処置する方法
US11406715B2 (en) 2015-05-30 2022-08-09 Genentech, Inc. Methods of treating HER2-positive metastatic breast cancer
WO2017087280A1 (en) 2015-11-16 2017-05-26 Genentech, Inc. Methods of treating her2-positive cancer
AU2017387909A1 (en) 2016-12-28 2019-06-27 Genentech, Inc. Treatment of advanced HER2 expressing cancer
SG11201905622VA (en) 2017-01-17 2019-08-27 Genentech Inc Subcutaneous her2 antibody formulations
US11077189B2 (en) 2017-03-02 2021-08-03 Genentech Inc. Adjuvant treatment of HER2-positive breast cancer
EP3615695A1 (en) 2017-04-24 2020-03-04 Genentech, Inc. Erbb2/her2 mutations in the transmebrane or juxtamembrane domain
AU2020456731A1 (en) 2020-06-29 2023-01-05 F. Hoffmann-La Roche Ag Pertuzumab plus trastuzumab fixed dose combination

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2095818B (en) 1981-03-27 1985-10-02 Exxon Research Engineering Co Staged adsorption/resorption heat pump
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
EP1400536A1 (en) * 1991-06-14 2004-03-24 Genentech Inc. Method for making humanized antibodies
WO1993021319A1 (en) 1992-04-08 1993-10-28 Cetus Oncology Corporation HUMANIZED C-erbB-2 SPECIFIC ANTIBODIES
CN101412758A (zh) 1996-10-18 2009-04-22 基因技术股份有限公司 抗ErbB2抗体
US7718387B2 (en) * 2001-09-20 2010-05-18 Board Of Regents, The University Of Texas System Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
ES2392525T3 (es) * 2002-07-15 2012-12-11 F. Hoffmann-La Roche Ag Tratamiento del cáncer con el anticuerpo dirigido contra ErbB2 rhuMAb 2C4

Also Published As

Publication number Publication date
EP1902315A1 (en) 2008-03-26
AU2006265275A1 (en) 2007-01-11
TWI312864B (en) 2009-08-01
WO2007003420A1 (en) 2007-01-11
ECSP088081A (es) 2008-02-20
MA29730B1 (fr) 2008-09-01
EP2194380A3 (en) 2010-07-14
CA2613187A1 (en) 2007-01-11
IL188317A0 (en) 2008-04-13
KR20080016939A (ko) 2008-02-22
AR053948A1 (es) 2007-05-23
EP2194380A2 (en) 2010-06-09
CR9635A (es) 2008-02-20
TW200741203A (en) 2007-11-01
NZ564471A (en) 2010-04-30
US20070009976A1 (en) 2007-01-11
MX2008000277A (es) 2008-03-24
RU2008103608A (ru) 2009-08-20
NO20076662L (no) 2008-04-03
BRPI0612591A2 (pt) 2010-11-23
JP2008545145A (ja) 2008-12-11

Similar Documents

Publication Publication Date Title
MY157955A (en) Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody
NZ609824A (en) Immunochromatography devices, methods and kits
WO2008070229A3 (en) Detection of pathogenic aggregates of protein in a sample by homologous elisa
MX363403B (es) Inmumoensayo con interferencia suprimida para la deteccion de anticuerpos anti-farmacos en muestras de suero.
WO2009023331A3 (en) Antibodies and improved test sample handling methods for use in assays for myeloperoxidase
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
WO2002037112A3 (en) Detection of ovarian cancer
MY145455A (en) Diagnostic biomolecule(s)
WO2011055968A3 (en) Kit for detecting bacterial infection comprising novel monoclonal antibodies
TW200801202A (en) Alpha-enolase specific antibody and method of use
MX2014010068A (es) Metodos y sistemas para amplificacion de señal de bioensayos.
SG164389A1 (en) Detection of a therapeutic antibody in an experimental animal
WO2007147141A3 (en) Methods for detecting molecular complexes
WO2007024735A3 (en) Method and antibodies for detecting nitrofuran
WO2008136510A1 (ja) 自己免疫性膵炎及び劇症1型糖尿病の検査方法及び検査試薬
WO2006004958A3 (en) Detection or measurement of antibodies to antigenic proteins in biological tissues or samples
WO2007037910A3 (en) Specific removal of activated immune cells
MY151190A (en) Method of detecting pork in processed food and detection kit therefor
WO2012141792A3 (en) Adiponectin receptor c-terminal fragments (ctf)-immunoglobulin
GB9913819D0 (en) Assay
WO2006060188A3 (en) Anti-tenascin monoclonal antibody immunoassays and diagnostic kits
GB0718603D0 (en) Methods
WO2007071250A3 (en) Method for detection of l523s expression in biological samples
IL201677A0 (en) Multi-immunoaffinity based antigen identification
WO2005074572A3 (en) Methods and compositions for detecting of equine tapeworm infections